Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Startbahn verifies $2.8m

Utec joined Dentsu in the fine art providence blockchain creator’s latest round, after supplying $900,000 of seed capital in July 2018.


Mar 20, 2019

Mojo Vision sets $58m series B scene

Stanford-StartX has contributed to a $58m series B for AR platform Mojo Vision, which also attracted Google, HP, Motorola Solutions, LG and Kakao.

Mar 20, 2019

Whispr negotiates $750,000

DTU-owned PreSeed Ventures joined Bose Ventures in occupational voice guidance technology developer Whispr’s round, which will help the startup double its headcount.

Mar 19, 2019

Saarland moulds Mac Panther Materials

Mac Panther Materials will operate as a subsidiary of manufacturing machinery supplier Mac Panther on the back of a spinout agreement with Saarland University.

Mar 19, 2019

Qart Medical instills funding

TAU-founded Qart Medical has been backed by the university’s Technology Innovation Momentum Fund and Chartered Investment Managers, itself a partner in TAU Ventures.

Mar 19, 2019

Wanda and Vortex to vacate stage

Embattled commercialisation firm NetScientific is closing two medical diagnostics spinouts from UCLA after both failed to attract external funding.

Mar 19, 2019

Ku climbs aboard new role

Katherine Ku has become a chief licensing adviser at law firm Wilson Sonsini Goodrich & Rosati after calling time on more than 27 years at Stanford’s OTL in June 2018.

Mar 19, 2019

Scottish universities sign up to Converge

Converge is now affiliated to all 18 Scottish universities, offering a prize fund of $305,000 through four competition-orientated programs.

Mar 18, 2019

CDL reaches Oxford

Toronto's Creative Destruction Lab accelerator network will open its first UK-based location through a partnership with University of Oxford after expanding into the US with NYU in 2018.

Mar 18, 2019

NervGen Pharma holds nerve for $7.5m IPO

CWRU-licensed NervGen Pharma floated at the top of its range on the TSX Venture Exchange, with the proceeds earmarked to push its lead candidate for spinal cord injury into the clinic.

Mar 18, 2019

Respirion inhales $14.2m

Cystic fibrosis drug developer Respirion Pharmaceuticals has spun out from Telethon Kids Institute with capital from an Australian government-backed initiative.

Mar 18, 2019

Big deal: Oxford PV begins capturing series D

Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.

Mar 18, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here